$24.7 Million is the total value of NanoDimension, Inc.'s 4 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TWST | TWIST BIOSCIENCE CORP | $10,845,000 | +0.8% | 307,740 | 0.0% | 43.99% | +24.9% | |
| SELB | Sell | SELECTA BIOSCIENCES INC | $6,212,000 | +18.5% | 3,787,515 | -5.4% | 25.20% | +46.8% |
| Sell | ICOSAVAX INC | $4,303,000 | -56.7% | 1,361,658 | -21.6% | 17.45% | -46.4% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $3,295,000 | -28.3% | 1,445,221 | 0.0% | 13.36% | -11.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICOSAVAX INC | 4 | Q3 2022 | 56.4% |
| TWIST BIOSCIENCE CORP | 4 | Q3 2022 | 44.0% |
| SELECTA BIOSCIENCES INC | 4 | Q3 2022 | 25.2% |
| SQZ BIOTECHNOLOGIES CO | 4 | Q3 2022 | 15.2% |
View NanoDimension, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-23 |
View NanoDimension, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.